Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yi-Jou Tai

Showing results (1-10 of 34) with videos related to

Pageof 4
Sort By:
Pharmaceuticals (Basel, Switzerland)|December 31, 2025
BTLA: An Emerging Immune Checkpoint Target in Cancer ImmunotherapyMing-Cheng Chang, Wan-Chi Lee, Yi-Jou Tai, et al.
Taiwanese Journal of Obstetrics & Gynecology|July 15, 2014
Solitary primary peritoneal carcinoma arising from the omentumYi-Jou Tai, Ming-Chieh Lin, Chin-Jui Wu, et al.
Taiwanese Journal of Obstetrics & Gynecology|May 15, 2023
Primary spontaneous inguinal endometriosis: Two cases with emphasis on the diagnostic approachChing-Wen Chou, Po-Ta Lai, Chu-Chun Huang, et al.
Gynecologic Oncology Reports|April 24, 2025
Warning factors of metachronous uterine cancer in patients with breast cancer: a real-world nationwide cohort studyYi-Jou Tai, Chung-Chen Lee, Yong-Chen Chen, et al.
Cancer Medicine|November 11, 2022
Outcome and prognostic factors of unexpected ovarian carcinomasChing-Yu Cheng, Heng-Cheng Hsu, Yi-Jou Tai, et al.
American Journal of Cancer Research|October 13, 2022
Overexpression of transmembrane protein 102 implicates poor prognosis and chemoresistance in epithelial ovarian carcinoma patientsYi-Jou Tai, Cheng-Miao Ou, Ying-Cheng Chiang, et al.
Journal of Gynecologic Oncology|December 16, 2020
Ovarian cancer risk score predicts chemo-response and outcome in epithelial ovarian carcinoma patientsHsiao Yun Lu, Yi Jou Tai, Yu Li Chen, et al.
Journal of Ovarian Research|May 1, 2026
A potential mutation-defined POLE/MMR/TP53 group classifications to stratify BRCA wild type epithelial ovarian cancerYi-Ting Chen, Po-Han Lin, Yi-Jou Tai, et al.
International Journal of Environmental Research and Public Health|July 21, 2019
Impact of Adjuvant Modalities on Survival in Patients with Advanced Stage Endometrial Carcinoma: A Retrospective Analysis from a Tertiary Medical CenterYi-Jou Tai, Heng-Cheng Hsu, Ying-Cheng Chiang, et al.
Scientific Reports|January 19, 2023
Age-specific trend and birth cohort effect on different histologic types of uterine corpus cancersYi-Jou Tai, Chun-Ju Chiang, Ying-Cheng Chiang, et al.
Pageof 4

Showing results (1-10 of 34) with videos related to

Sort By:
Pageof 4
Pharmaceuticals (Basel, Switzerland)|December 31, 2025
BTLA: An Emerging Immune Checkpoint Target in Cancer ImmunotherapyMing-Cheng Chang, Wan-Chi Lee, Yi-Jou Tai, et al.
Taiwanese Journal of Obstetrics & Gynecology|July 15, 2014
Solitary primary peritoneal carcinoma arising from the omentumYi-Jou Tai, Ming-Chieh Lin, Chin-Jui Wu, et al.
Taiwanese Journal of Obstetrics & Gynecology|May 15, 2023
Primary spontaneous inguinal endometriosis: Two cases with emphasis on the diagnostic approachChing-Wen Chou, Po-Ta Lai, Chu-Chun Huang, et al.
Gynecologic Oncology Reports|April 24, 2025
Warning factors of metachronous uterine cancer in patients with breast cancer: a real-world nationwide cohort studyYi-Jou Tai, Chung-Chen Lee, Yong-Chen Chen, et al.
Cancer Medicine|November 11, 2022
Outcome and prognostic factors of unexpected ovarian carcinomasChing-Yu Cheng, Heng-Cheng Hsu, Yi-Jou Tai, et al.
American Journal of Cancer Research|October 13, 2022
Overexpression of transmembrane protein 102 implicates poor prognosis and chemoresistance in epithelial ovarian carcinoma patientsYi-Jou Tai, Cheng-Miao Ou, Ying-Cheng Chiang, et al.
Journal of Gynecologic Oncology|December 16, 2020
Ovarian cancer risk score predicts chemo-response and outcome in epithelial ovarian carcinoma patientsHsiao Yun Lu, Yi Jou Tai, Yu Li Chen, et al.
Journal of Ovarian Research|May 1, 2026
A potential mutation-defined POLE/MMR/TP53 group classifications to stratify BRCA wild type epithelial ovarian cancerYi-Ting Chen, Po-Han Lin, Yi-Jou Tai, et al.
International Journal of Environmental Research and Public Health|July 21, 2019
Impact of Adjuvant Modalities on Survival in Patients with Advanced Stage Endometrial Carcinoma: A Retrospective Analysis from a Tertiary Medical CenterYi-Jou Tai, Heng-Cheng Hsu, Ying-Cheng Chiang, et al.
Scientific Reports|January 19, 2023
Age-specific trend and birth cohort effect on different histologic types of uterine corpus cancersYi-Jou Tai, Chun-Ju Chiang, Ying-Cheng Chiang, et al.
Pageof 4